Xiao Juan Li

Director/Board Member at CHINA NATIONAL MEDICINES CORPORATION LTD.

48 year

Health Technology

Profile

Xiao Juan Li is currently a Director at China National Medicines Co., Ltd.
Prior to this, she worked as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and as a Manager-Investment Planning & Audit Division at China National Pharmaceutical Industry Corp.
Ltd.

Xiao Juan Li active positions

Companies	Position	Start
CHINA NATIONAL MEDICINES CORPORATION LTD.	Director/Board Member	2022-04-06

All active positions of Xiao Juan Li

Former positions of Xiao Juan Li

Companies	Position	End
China National Pharmaceutical Industry Corp. Ltd. China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China.	Corporate Officer/Principal	-
JIANGSU HENGRUI MEDICINE CO., LTD.	Director/Board Member	-

See the detail of Xiao Juan Li's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xiao Juan Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
JIANGSU HENGRUI MEDICINE CO., LTD.	Health Technology
CHINA NATIONAL MEDICINES CORPORATION LTD.	Health Technology

Private companies	1
China National Pharmaceutical Industry Corp. Ltd. China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China.	Health Technology